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Abstract
Introduction: Certain Staphylococcus aureus strains produce Panton-Valentine leukocidin, a toxin that lyses white
blood cells causing extensive tissue necrosis and chronic, recurrent or severe infection. This report documents a
confirmed case of methicillin-sensitive Staphylococcus aureus strain harboring Panton-Valentine leukocidin genes
from Trinidad and Tobago. To the best of our knowledge, this is the first time that such a case has been identified
and reported from this country.
Case presentation: A 13-year-old Trinidadian boy of African descent presented with upper respiratory symptoms
and gastroenteritis-like syptoms. About two weeks later he was re-admitted to our hospital complaining of pain
and weakness affecting his left leg, where he had received an intramuscular injection of an anti-emetic drug. He
deteriorated and developed septic arthritis, necrotizing fasciitis and septic shock with acute respiratory distress
syndrome, leading to death within 48 hours of admission despite intensive care treatment. The infection was
caused by S. aureus. Bacterial isolates from specimens recovered from our patient before and after his death were
analyzed using microarray DNA analysis and spa typing, and the results revealed that the S. aureus isolates
belonged to clonal complex 8, were methicillin-susceptible and positive for Panton-Valentine leukocidin. An
autopsy revealed multi-organ failure and histological tissue stains of several organs were also performed and
showed involvement of his lungs, liver, kidneys and thymus, which showed Hassal’s corpuscles.
Conclusion: Rapid identification of Panton-Valentine leukocidin in methicillin-sensitive S. aureus isolates causing
severe infections is necessary so as not to miss their potentially devastating consequences. Early feedback from the
clinical laboratories is crucial.
Introduction
Staphylococcus aureus has a variety of different virulence
factors. Among these, there are hemolysins and leukoci-
dins [1]. A minority of S. aureus strains carry bi-compo-
nent leukocidin. Its genes, lukS-PV and lukF-PV,a r e
encoded on prophages and can be found in diverse
genetic lineages of S. aureus. This toxin lyses white
blood cells, causing extensive tissue necrosis and severe
infection. Strains which are positive for this leukocidin
are usually associated with community-acquired infec-
tions which generally affect previously healthy children
and young adults. It was first described in 1932 by Pan-
ton and Valentine [2] and is therefore known as Pan-
ton-Valentine leukocidin, or PVL.
Recently the issue of the emergence of novel, commu-
nity-acquired methicillin-resistant S. aureus (MRSA)
strains being positive for PVL has been emphasized.
However, PVL is also common in methicillin-susceptible
S. aureus (MSSA) and can be detected in as much as
30% of abscess isolates [3]. In MSSA, it is frequently not
diagnosed as there are no phenotypic features or rapid,
non-molecular assays available. For that reason, clinical
isolates from cases with suspected PVL-associated dis-
ease (chronic, recurrent or unusually severe skin and
soft tissue infections, necrotizing pneumonia or fasciitis)
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whether they were MRSA or MSSA.
There are no previously documented cases of infection
by S. aureus producing PVL in Trinidad and Tobago
and the Caribbean regions. Although the prevalence of
MRSA have been reported in Trinidad and Tobago [4],
there has never been any report of S. aureus carrying
PVL genes in this country. We describe here the first
confirmed case from Trinidad and Tobago, or, in fact,
from any English speaking Caribbean island, of a fatal
multi-organ failure caused by a PVL-producing MSSA
infection in a previously healthy child. This report stres-
ses the fact that invasive infections due to MSSA could
have innocuous symptoms, should not be treated lightly
since such infections may have a high mortality rate,
and that PVL in MSSA still remains a clinically impor-
tant issue.
Case presentation
This is a report of a previously active and healthy 13-
year-old Trinidadian boy of African descent with no
past medical history, significant history of trauma or tra-
vel abroad. He suddenly presented with flu-like symp-
toms, vomiting and diarrhea of four days duration at a
community health center. There was no history of
known contact with S. aureus infection either at school
or with family. He was assessed as a case of viral illness,
possibly gastroenteritis, and was treated symptomatically
with anti-emetic and analgesic intramuscular injections.
Laboratory tests were not pursued and he was dis-
charged with instructions for home care and, if neces-
sary, oral rehydration therapy. About two weeks later he
was admitted to the hospital complaining of fever,
increasing pain, weakness and inability to lift or to move
his left leg where he received an intramuscular injection
of the anti-emetic drug.
On admission, his physical examination revealed
tender and warm erythematous swelling of his left
thigh extending to his upper thigh and hip joint. An
ultrasound scan of his left hip, a chest X-ray, electro-
cardiography and Doppler ultrasound of his popliteal
pulses detected no abnormality. Blood cultures, sam-
ples of pus from a skin rash and samples for clinical
chemistry were taken. Initial laboratory results are
g i v e ni nT a b l e1 .
On further review, the child was assessed as having
septic arthritis with a high suspicion of necrotizing fas-
ciitis and septicemia or infective endocarditis. Thus,
treatment with clindamycin, ceftriaxone, vancomycin
and cloxacillin was started. Later the same day, the cel-
lulitic area around his right knee was noticed to increase
rapidly and a computed tomography scan revealed a col-
lection or abscess around his left hip but not involving
the capsule of the joint. An immediate exploratory
laparotomy and drainage of the pelvic wall abscess
under general anesthesia was arranged. During the
operation, 200 ml of straw colored fluid was collected
and a deep pelvic wall abscess was found, measuring 8
× 6 × 4 cm, adjoining his hip joint capsule and near to
the obturator canal. There was thick shiny brown pus in
the cavity extending superiorly towards the inlet of his
iliac bone, inferiorly to the superior and inferior ramus
of his left pelvic bone. The thick joint capsule was intact
and there was no evidence of gluteal abscess, but there
was a compression from the external and greater tuber-
osity of the hip bone by the thick pus collection. The
pus was drained. Our patient was transferred to the
intensive care unit (ICU) although the post-operative
condition was very satisfactory. While in the ICU, our
patient started to have persistent cough productive of
white sputum and was observed to have bilateral crepi-
tations in all his lung fields. A chest X-ray was sugges-
tive of acute respiratory distress syndrome with ground
glass appearance. He required inotropes, and had diffi-
culty ventilating resulting in the need for intubation and
artificial ventilation. However, our patient’s condition
deteriorated rapidly and he died 48 hours after admis-
sion. An autopsy was remarkable for necrotizing multi-
organ failure involving his lungs, kidneys, thymus and
other organs. It also revealed congestion, edema and
hemorrhage of his lung alveoli, necrosis of his kidney
epithelia and Hassall’s corpuscles and microabscesses of
his thymus gland.
Table 1 Laboratory clinical chemistry results of a fatal
case of methicillin-sensitive Staphylococcus aureus
producing PVL gene in Trinidad and Tobago
Indices Referral Center On admission Normal values
WBC 3.2 1.5 4-11 × 10
9/L
Hemoglobin 11.2 2.3 11.5 -13.5 g/dL
HCT 30.7 23.8 40-45%
ESR NT 89 0-15 mm/L
Platelet 148 81 150 -400 × 10
9/L
Calcium 7.6 7.5 8.4-11.5 mg/dL
Chloride 103 110 92-118 mmol/L
Creatinine 0.9 1.9 0.2- 1.7 mg/dL
CRP 15 90 0-10 mg/dL
Potassium 3.8 7 3.6-5.8 mmol/L
Sodium 138 140 130-148 mmol/L
BUN 13 40 4-24 mg/dL
Uric acid 5.6 13 2.5- 9.0 mg/dL
Phosphorus 4.3 15.1 2.5- 6.5 mg/dL
ALT 34 1211 4- 48U/L
ALP 215 241 38-151U/L
Total Protein 4.9 4.4 6.3-8.6 g/dL
WBC = white cell count; HCT = hematocrit %; ESR = erythrocyte segmentation
rate; NT = not tested; CRP = C-Reactive Protein; BUN = Blood Urea Nitrogen;
ALT = Alanine transaminases, ALP = Alkaline phosphatase
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patient revealed grossly abnormal data. These are also
shown on Table 1.
Microbiological diagnosis and molecular analysis
of bacterial isolates
Blood, pus and post-mortem specimens yielded growth
of S. aureus as identified by Gram stain, catalase and
coagulase reactions and by biochemistry (MicroScan
Walk Away 96 SI, Siemens). The isolates were suscepti-
ble to several antibiotics including oxacillin as shown on
Table 2. Swab materials from the autopsy also yielded S.
aureus with same anti-microbial susceptibility pattern.
Blood cultures also yielded S. aureus.
The isolates from blood specimens and from swab and
tissue specimens at autopsy were further analyzed using
spa typing [5] and microarray analysis [6]. This allowed
us to detect virulence- and resistance-associated genes
as well as to assign the isolates to clonal complexes
(CC).
The two genotyped isolates were identical and their
overall hybridization profile allowed assignation to CC8.
Species markers or regulatory genes, including 23S-
rRNA gene, katA (encoding catalase), coA (coagulase)
and spa (Protein A) were all positive. The isolates did
not harbor mecA nor did any other genes associated
with staphylococcal chromosomal cassette mec elements.
Genes blaZ (beta lactamase) and associated regulatory
genes blaIa n dblaRa sw e l la sfosB (putative resistance
marker for fosfomycin, bleomycin) were detected. The
isolates carried the hemolysin gamma locus (lukF, lukS,
hlgA) as well as the genes encoding PVL (lukF-PV, lukS-
PV). The enterotoxin genes entD, entJ, entK, entQa n d
entR( sed, sej, sek, seq, ser) were found, but other entero-
toxin genes were not present. The isolates belonged to
agr g r o u pIa n dc a p s u l et y p e5 .G e n e se n c o d i n ga d h e -
sion factors (microbial surface components recognizing
adhesive matrix molecules) such as bone sialoprotein-
binding protein (bbp), clumping factor A and B (clfA
and clfB), cell-wall associated fibronectin-binding pro-
tein (ebh), immune invasion genes isaB (immunodomi-
nant antigen B), isdA (heme/transferin-binding protein),
lmrP (putative transporter protein) and genes encoding
staphylococcal superantigen-like proteins were also pre-
sent in these isolates, and their allelic variants were in
accordance to CC8 affiliation.
The spa typing analysis revealed the isolate to be spa
type t400. This is quite an uncommon spa type, and has
only previously been reported from northern Europe [7].
It has also been observed in a PVL-negative mutant of
the MRSA strain USA300 (P N Levett, personal commu-
nication). Since this strain also belongs to CC8, this
confirms the assignment of our isolates to that complex.
The repeat pattern of spa type t400 (11-19-12-21-17-34-
34-22-25) is related to other clonal complex 8 spa types
(such as t008, 11-19-12-21-17-34-24-34-22-25 or t009,
11-12-21-17-34-24-34-22-24-34-22-33-25).
Discussion
This case showed an unusually severe clinical presenta-
tion. This is similar to previous reports on PVL-produ-
cing S. aureus [8] causing conditions such as necrotizing
pyogenic skin infections, cellulitis, tissue necrosis, septic
arthritis, bacteremia, purpura fulminans (typically char-
acterized by disseminated intravascular coagulation and
purpuric skin lesions) and community-acquired necro-
tizing pneumonia.
PVL disease often can be observed in young and
healthy people without previous medical history, who
might be in close contact to others due to accommoda-
tion in barracks or dormitories, or who might be
engaged in close contact sport. These risk factors are
conceivable in a school child. PVL-positive S. aureus
have also been transmitted by contaminated articles like
sharing towels, razors, poor hand hygiene or illicit drug
use. In our case, a transmission by intramuscular injec-
tion appears possible, but cannot be proven
retrospectively.
The causative strain belonged to CC8. It lacked some
of the most prevalent enterotoxins (egc-cluster) as well
as exfoliative toxins (etA, etBo retD) and epidermal cell
differentiation inhibitors (edinA, edinBo redinC). On
the other hand, it carried, beside PVL, several different
Table 2 Antimicrobial susceptibility test results of a
methicillin sensitive Staphylococcus aureus producing PVL
gene in Trinidad and Tobago
Drug MIC (μ/mL) Interpretation
Ampicillin > 8 R
Amoxycilin/Clavulanic < 4/2 S
Cefazolin < 2 S
Ciprofloxacin < 1 S
Clindamycin < 1 S
Erythromycin > 4 R
Gentamicin > 8 R
Imipenem < 1 S
Levofloxacin < 2 S
Linezolid < 4 S
Oxacillin < 0.25 S
Penicillin > 8 R
Piperacillin/Tazobactam < 1 S
Rifampin < 1 S
Synercid 0.5 S
Tetracycline < 4 S
Trimethoprim/Sulfamethoxazole < 2/38 S
Vancomycin < 2 S
S = susceptible; R = resistant
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role of these toxins, a possible impact on the virulence,
and possible synergistic effects are not yet understood.
Thus it cannot be determined how much they contribu-
ted to the fatal course of the disease in addition to the
PVL. PVL alone is a potent virulence factor, especially
with regard to skin and/or soft tissue infections and
pneumonia. While enterotoxin genes sed, sej and ser are
common in that clonal complex [8], PVL appears to be
rare among CC8-MSSA. The majority of PVL-MSSA
infections from geographic areas other than Trinidad
and Tobago can be attributed to other clonal complexes,
such as CC1, CC5, CC22, CC30, CC80, CC121 and
CC152 [3,10]. This could suggest geographic differences
in the molecular epidemiology of the PVL-producing
MSSA. While PVL genes are uncommon in CC8-MSSA,
there is a common and widespread MRSA strain from
the same lineage, which is known as USA300. Interest-
ingly, this strain has also been described in Colombia
[11], geographically close to Trinidad and Tobago. Thus
it is tempting to speculate on a possible phylogenetic
relationship between USA300 and the strain described
in this study. Further investigations on PVL-positive S.
aureus in the southern Caribbean and South America
are warranted.
Unfortunately, some symptoms, including the hypo-
tension, tachycardia, leukocytopenia, and abnormal liver
function tests suggestive of shock, were not adequately
addressed until our patient was admitted into the ICU.
Some laboratory reports arrived at the ICU only after
the death of our patient. Information on the presence of
PVL was also obtained only after our patient died. Such
problems commonly plague health care providers in the
developing world where the facilities and technologies
are often not readily available.
The autopsy findings and histological reports proved
the involvement of the lungs and consequently their
failure. Except for the vague history of flu-like symp-
toms and the persistent productive cough of whitish
sputum noted during the last few hours of his life,
there were no major clinical features that suggested
pneumonia. An involvement of the kidneys was also
noted in this patient in the autopsy findings. These
findings emphasize the need for aggressive manage-
ment of cases of infections by PVL producing S. aur-
eus organisms since it appears that no organ or tissues
can be spared.
By both phenotypical and molecular methods, it was
shown that this strain was susceptible to several relevant
antibiotics. A combination of a bactericidal drug, such
as a beta-lactam, plus a compound that reduces toxin
synthesis, such as clindamycin or rifampicin, is strongly
advocated since beta-lactams alone have in vitro been
shown to increase PVL in synthesis studies [12].
However, susceptibility tests need to be performed
urgently in order to assess the efficiency of the therapy
and to rule out PVL-MRSA. Thus, the initial choice of
antibiotics in the presented case appeared to be correct,
but nevertheless the case resulted in a fatal outcome.
This emphasizes the severity of PVL-associated disease.
Conclusion
Given the ability of PVL-producing S. aureus (either
MSSA or MRSA) to cause life-threatening disease, and
the absence of any rapid non-molecular tests for PVL,
the crucial role of awareness cannot be over-empha-
sized. This report provides timely and informative hints
to all health care facilities, on a local or regional level,
that clinical presentation of PVL-producing S. aureus
infections should not be underestimated. It is also the
first report of a confirmed case of PVL-producing S.
aureus in Trinidad and Tobago and in the English
speaking Caribbean islands.
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